Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | BMY | AMGN | GILD | REGN |
| Company | Nabriva Therapeutics Plc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4500 | 48.45 | 266.83 | 67.80 | 897.22 |
| High | 1.9000 | 48.60 | 267.51 | 67.89 | 901.07 |
| Low | 1.3500 | 48.24 | 263.81 | 67.19 | 890.43 |
| Last | 1.4200 | 48.39 | 265.49 | 67.45 | 895.54 |
| Change | unch | -0.12 | -0.02 | -0.30 | -3.02 |
| % Change | unch | -0.25% | -0.01% | -0.44% | -0.34% |
| Volume | 717,200 | 8,342,499 | 1,164,478 | 2,876,104 | 326,597 |
| 20-Day Average Volume | 46,640 | 11,343,088 | 2,224,095 | 6,316,699 | 420,549 |
| Previous Close | 1.4200 | 48.51 | 265.51 | 67.75 | 898.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 51.37 | 273.83 | 70.93 | 945.62 |
| 20-Day Raw Stochastic | 12.73% | 5.48% | 4.27% | 3.17% | 6.53% |
| 20-Day Relative Strength | 42.54% | 36.78% | 38.30% | 30.85% | 32.26% |
| Weighted Alpha | -50.30 | -29.82 | +5.50 | -23.29 | +12.33 |
| Today's Opinion | 100% Sell | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Sell | 8% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | -6.07% since 04/09/24 | -1.98% since 04/09/24 | -3.62% since 04/09/24 | -5.05% since 04/09/24 |
| Low | 1.3500 on 07/31/23 | 48.12 on 04/15/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 890.43 on 04/16/24 |
| High | 1.9000 on 07/31/23 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 937.87 on 04/10/24 |
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | -7.40% since 03/15/24 | -1.44% since 03/15/24 | -8.52% since 03/15/24 | -7.08% since 03/15/24 |
| Low | 1.3500 on 07/31/23 | 48.12 on 04/15/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 890.43 on 04/16/24 |
| High | 1.9000 on 07/31/23 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | -3.06% since 01/16/24 | -12.68% since 01/16/24 | -21.61% since 01/16/24 | -4.38% since 01/16/24 |
| Low | 1.3500 on 07/31/23 | 47.58 on 02/06/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 890.43 on 04/16/24 |
| High | 2.2400 on 05/19/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | -15.22% since 10/16/23 | -7.63% since 10/16/23 | -14.89% since 10/16/23 | +6.23% since 10/16/23 |
| Low | 1.2600 on 03/27/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 769.19 on 10/27/23 |
| High | 2.2400 on 05/19/23 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 98,318,080 | 142,291,856 | 84,353,968 | 98,627,744 |
| Shares Outstanding, K | 32,015 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 36,940,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -57,190,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 7,590,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -8,700,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.53 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 08/02/23 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 24.07 |